Company Name	BioDiem Limited
Subsidiary	Opal Biosciences Limited
Registered Office	Level 4 100 Albert Road South Melbourne, VIC 3205 Australia (Effective from 25 October 2013)
Principal Place of Office	Level 4 100 Albert Road South Melbourne, VIC 3205 Australia (Effective from 25 October 2013)
Sector	Biotechnology / Medical / Life Science / Pharmaceutical
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities	Development and commercialisation of pharmaceutical and biomedical research. Securing licences for its range of biopharmaceutical products currently under development.
Internet Homepage Address (URL)	http://www.biodiem.com/
Phone Number	(61) 3 9692 7240 (as from 25 October 2013)
Fax Number	(61) 3 9077 9233 (as from 25 October 2013)
Email Address	info@biodiem.com
Financial Year End	June 30
Board of Directors	Mr. Hugh M Morgan AC, Chairman, Non-Executive Director Ms. Julie Phillips, Executive Director Prof. Larisa Rudenko, Non-Executive Director
Management Team	Ms. Julie Phillips, CEO Ms. Cathy Cropp, Projects Manager Ms Melanie Leydin, Company Secretary [Appointed on 14 November 2012] and CFO
Company Secretary	Ms Melanie Leydin [Appointed on 14 November 2012]
Investor Relations Contact	Ms Julie Phillips, Director and CEO
Bankers	National Australia Bank Level 2, 151 Rathdowne Street Carlton, VIC 3053 Australia
Auditors	Grant Thornton Audit Pty Ltd The Rialto, Level 30 525 Collins Street Melbourne VIC 3000 Australia Phone : (61) 3 8320 2222 Fax : (61) 3 8320 2200 Email: info.vic@au.gt.com
Legal Counsel	David Rodda, Partner, Commercial Quinert Rodda & Associates Suite 1, Level 6, 50 Queen Street, Melbourne, VIC 3000, Australia Phone : (61) 3 8692 9000 Fax : (61) 3 8692 9040
Share Registries	Computershare Investor Services Pty Limited Yarra Falls, 452 Johnston Street, Abbotsford, VIC 3067, Australia Phone : (61) 3 9415 5000 Investor Queries (within Australia): 1300 850 505 Fax: (61) 3 9473 2500 www.computershare.com.au
Secondary Market Services	Shareholders who have enquiries in relation to buying, selling, or investing in the Company or require info on any recent changes in the Register of interest, please contact: DFS Equities Contact: Mr. Jim Purnell Phone : (61) 2 9844 5458 (dedicated line for BioDiem enquiries) Fax : (61) 2 9844 5445 email : jpurnell@dfsequities.com.au Address : Suite 1A, Level 2, 802 Pacific Highway, Gordon, NSW 2072, Australia
ASX Stock Code	BDM
Listing Date	28 January 2004
De-listing	8 November 2013 Suspension Date - effective date of suspension of trading of BioDiem securities BDM and BDMO on ASX 15 November 2013 Delisting Date - effective date of removal of BioDiem from the official list of ASX
Total Issued Shares	167,361,644 (as of 22 June 2015)
Issued Options / Warrants	0 N/A
Capital Raised	$30,429,799 net of share issue costs since inception (as at 31 May 2015)
Cash	$883,372 in cash and cash equivalents (as of 31 December 2014)
Market Capitalisation	$8.7m (as of 22 May 2015) $9m (as of 30 April 2014) $4.3 m (as of 28 October 2013) $5.7 m (as of 20 September 2013) $11.4m (as of end of July 2013) $4.26m (as of 30 May 2013) $5.12m (as of 31 March 2013) $6m (as of 28 February 2013) $5.68m (as of 12 February 2013)
Shareholders	857 (as of 22 June 2014)
Substantial Shareholders	Citicorp Nominees Pty Ltd     56,011,674 33.47% Brezzo Enterprises Ltd     45,119,964 26.96%     (as of 22 June 2015)
Top 20 holders	Hold 138,411,759 ordinary fully paid shares, amounting to 82.7% of units
Year of Inception	18 May 2001
ABN	20 096 845 993
ACN	096 845 993